vs
Side-by-side financial comparison of Gevo, Inc. (GEVO) and PETMED EXPRESS INC (PETS). Click either name above to swap in a different company.
Gevo, Inc. is the larger business by last-quarter revenue ($45.3M vs $40.7M, roughly 1.1× PETMED EXPRESS INC). Gevo, Inc. runs the higher net margin — -13.2% vs -26.0%, a 12.7% gap on every dollar of revenue. On growth, Gevo, Inc. posted the faster year-over-year revenue change (695.6% vs -23.3%). Gevo, Inc. produced more free cash flow last quarter ($8.7M vs $-9.2M). Over the past eight quarters, Gevo, Inc.'s revenue compounded faster (237.1% CAGR vs -20.9%).
Gevo, Inc. is an American renewable chemicals and advanced biofuels company headquartered in unincorporated Douglas County, Colorado, in the Denver-Aurora metropolitan area. Gevo operates in the sustainability sector, pursuing a business model based on the concept of the "circular economy". The company develops bio-based alternatives to petroleum-based products using a combination of biotechnology and classical chemistry. Gevo uses the GREET model from Argonne National Laboratory as a basis f...
PetMed Express, Inc., also known as PetMeds, is an online pet pharmacy based in the United States. It is publicly traded and sells prescription and non-prescription pet medication.
GEVO vs PETS — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $45.3M | $40.7M |
| Net Profit | $-6.0M | $-10.6M |
| Gross Margin | — | 23.3% |
| Operating Margin | -4.8% | -25.7% |
| Net Margin | -13.2% | -26.0% |
| Revenue YoY | 695.6% | -23.3% |
| Net Profit YoY | 65.9% | -1392.6% |
| EPS (diluted) | $-0.03 | $-0.50 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $45.3M | $40.7M | ||
| Q3 25 | $42.7M | $44.4M | ||
| Q2 25 | $43.4M | $51.2M | ||
| Q1 25 | $29.1M | $50.8M | ||
| Q4 24 | $5.7M | $52.0M | ||
| Q3 24 | $2.0M | $58.0M | ||
| Q2 24 | $5.3M | $66.2M | ||
| Q1 24 | $4.0M | $65.1M |
| Q4 25 | $-6.0M | $-10.6M | ||
| Q3 25 | $-8.0M | $-8.5M | ||
| Q2 25 | $2.1M | $-34.2M | ||
| Q1 25 | $-21.7M | $-11.6M | ||
| Q4 24 | $-17.6M | $-707.0K | ||
| Q3 24 | $-21.2M | $2.3M | ||
| Q2 24 | $-21.0M | $3.8M | ||
| Q1 24 | $-18.9M | $-5.0M |
| Q4 25 | — | 23.3% | ||
| Q3 25 | — | 28.0% | ||
| Q2 25 | — | 28.1% | ||
| Q1 25 | — | 29.9% | ||
| Q4 24 | — | 31.0% | ||
| Q3 24 | — | 32.3% | ||
| Q2 24 | — | 28.8% | ||
| Q1 24 | — | 29.3% |
| Q4 25 | -4.8% | -25.7% | ||
| Q3 25 | -8.6% | -18.9% | ||
| Q2 25 | 13.4% | -66.7% | ||
| Q1 25 | -69.2% | -11.9% | ||
| Q4 24 | -344.7% | -0.9% | ||
| Q3 24 | -1221.8% | 1.0% | ||
| Q2 24 | -456.8% | 6.6% | ||
| Q1 24 | -580.0% | -5.9% |
| Q4 25 | -13.2% | -26.0% | ||
| Q3 25 | -18.6% | -19.2% | ||
| Q2 25 | 4.9% | -66.7% | ||
| Q1 25 | -74.6% | -22.9% | ||
| Q4 24 | -308.9% | -1.4% | ||
| Q3 24 | -1076.6% | 4.0% | ||
| Q2 24 | -399.3% | 5.7% | ||
| Q1 24 | -473.1% | -7.7% |
| Q4 25 | $-0.03 | $-0.50 | ||
| Q3 25 | $-0.03 | $-0.41 | ||
| Q2 25 | $0.01 | $-1.65 | ||
| Q1 25 | $-0.09 | $-0.56 | ||
| Q4 24 | $-0.08 | $-0.03 | ||
| Q3 24 | $-0.09 | $0.11 | ||
| Q2 24 | $-0.09 | $0.18 | ||
| Q1 24 | $-0.08 | $-0.24 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $81.2M | $26.9M |
| Total DebtLower is stronger | $164.8M | — |
| Stockholders' EquityBook value | $466.3M | $32.8M |
| Total Assets | $718.9M | $88.0M |
| Debt / EquityLower = less leverage | 0.35× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $81.2M | $26.9M | ||
| Q3 25 | $72.6M | $36.1M | ||
| Q2 25 | $57.3M | $41.1M | ||
| Q1 25 | $65.3M | $54.7M | ||
| Q4 24 | $189.4M | $50.1M | ||
| Q3 24 | $223.2M | $52.0M | ||
| Q2 24 | $245.7M | $46.0M | ||
| Q1 24 | $270.6M | $55.3M |
| Q4 25 | $164.8M | — | ||
| Q3 25 | $164.5M | — | ||
| Q2 25 | $167.5M | — | ||
| Q1 25 | $167.0M | — | ||
| Q4 24 | $67.1M | — | ||
| Q3 24 | $67.0M | — | ||
| Q2 24 | $66.8M | — | ||
| Q1 24 | $68.3M | — |
| Q4 25 | $466.3M | $32.8M | ||
| Q3 25 | $468.9M | $43.1M | ||
| Q2 25 | $474.1M | $51.5M | ||
| Q1 25 | $469.8M | $85.1M | ||
| Q4 24 | $489.5M | $96.2M | ||
| Q3 24 | $504.7M | $96.4M | ||
| Q2 24 | $522.7M | $93.5M | ||
| Q1 24 | $541.9M | $96.7M |
| Q4 25 | $718.9M | $88.0M | ||
| Q3 25 | $685.2M | $100.3M | ||
| Q2 25 | $702.1M | $109.8M | ||
| Q1 25 | $677.8M | $148.7M | ||
| Q4 24 | $583.9M | $144.8M | ||
| Q3 24 | $583.9M | $146.0M | ||
| Q2 24 | $617.9M | $152.7M | ||
| Q1 24 | $633.6M | $169.9M |
| Q4 25 | 0.35× | — | ||
| Q3 25 | 0.35× | — | ||
| Q2 25 | 0.35× | — | ||
| Q1 25 | 0.36× | — | ||
| Q4 24 | 0.14× | — | ||
| Q3 24 | 0.13× | — | ||
| Q2 24 | 0.13× | — | ||
| Q1 24 | 0.13× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $20.0M | $-9.2M |
| Free Cash FlowOCF − Capex | $8.7M | $-9.2M |
| FCF MarginFCF / Revenue | 19.3% | -22.7% |
| Capex IntensityCapex / Revenue | 24.7% | 0.1% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-43.5M | $-23.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $20.0M | $-9.2M | ||
| Q3 25 | $-6.8M | $-2.2M | ||
| Q2 25 | $-2.5M | $-12.3M | ||
| Q1 25 | $-24.0M | $7.0M | ||
| Q4 24 | $-18.8M | $-1.2M | ||
| Q3 24 | $-11.0M | $7.4M | ||
| Q2 24 | $-11.4M | $-8.5M | ||
| Q1 24 | $-16.1M | $7.1M |
| Q4 25 | $8.7M | $-9.2M | ||
| Q3 25 | $-14.6M | $-4.8M | ||
| Q2 25 | $-7.8M | $-13.6M | ||
| Q1 25 | $-29.9M | $4.6M | ||
| Q4 24 | $-33.5M | $-1.9M | ||
| Q3 24 | $-20.8M | $6.1M | ||
| Q2 24 | $-20.6M | $-9.2M | ||
| Q1 24 | $-33.6M | $5.9M |
| Q4 25 | 19.3% | -22.7% | ||
| Q3 25 | -34.2% | -10.8% | ||
| Q2 25 | -17.9% | -26.5% | ||
| Q1 25 | -102.7% | 9.1% | ||
| Q4 24 | -587.2% | -3.7% | ||
| Q3 24 | -1057.0% | 10.6% | ||
| Q2 24 | -392.4% | -13.9% | ||
| Q1 24 | -841.9% | 9.0% |
| Q4 25 | 24.7% | 0.1% | ||
| Q3 25 | 18.3% | 5.9% | ||
| Q2 25 | 12.1% | 2.5% | ||
| Q1 25 | 20.0% | 4.7% | ||
| Q4 24 | 256.6% | 1.5% | ||
| Q3 24 | 496.2% | 2.2% | ||
| Q2 24 | 174.8% | 1.0% | ||
| Q1 24 | 438.9% | 1.9% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -1.18× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 3.18× | ||
| Q2 24 | — | -2.27× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GEVO
Segment breakdown not available.
PETS
| Reorder | $34.0M | 84% |
| New Order | $5.0M | 12% |
| Membership Fees | $1.6M | 4% |
